Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 08:12 am Sale | 2025-09-30 | 13G | enGene Holdings Inc. ENGN | Deep Track Capital, LP | 2,239,353 4.370% | -2,318,222 (-50.87%) | Filing History |
| 2025-11-14 08:09 am Sale | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Deep Track Capital, LP | 0 0.000% | -2,357,702 (Position Closed) | Filing History |
| 2025-11-14 08:09 am Sale | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Deep Track Capital, LP | 0 0.000% | -114,775 (Position Closed) | Filing History |
| 2025-11-14 08:08 am Sale | 2025-09-30 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 2,568,613 0.970% | -12,703,559 (-83.18%) | Filing History |
| 2025-11-12 4:02 pm Purchase | 2025-11-05 | 13G | MoonLake Immunotherapeutics MLTX | Deep Track Capital, LP | 4,610,071 6.460% | 4,610,071 (New Position) | Filing History |
| 2025-11-04 4:06 pm Purchase | 2025-10-28 | 13G | Cybin Inc. Common Stock HELP | Deep Track Capital, LP | 3,072,250 6.090% | 2,072,250 (+207.22%) | Filing History |
| 2025-10-29 4:13 pm Purchase | 2025-09-30 | 13G | Cybin Inc. Common Stock HELP | Deep Track Capital, LP | 1,000,000 3.970% | 1,000,000 (New Position) | Filing History |
| 2025-10-09 4:52 pm Purchase | 2025-10-02 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Deep Track Capital, LP | 1,484,513 5.330% | 1,484,513 (New Position) | Filing History |
| 2025-10-08 4:05 pm Purchase | 2025-10-01 | 13G | Palisade Bio, Inc. PALI | Deep Track Capital, LP | 10,012,958 9.990% | 10,012,958 (New Position) | Filing History |
| 2025-10-07 4:34 pm Purchase | 2025-09-30 | 13G | Akero Therapeutics, Inc. AKRO | Deep Track Capital, LP | 4,400,000 5.500% | 4,400,000 (New Position) | Filing History |
| 2025-09-19 4:30 pm Purchase | 2025-09-12 | 13D | LB Pharmaceuticals Inc Common Stock LBRX | Deep Track Capital, LP | 3,352,804 14.900% | 3,352,804 (New Position) | Filing History |
| 2025-08-25 7:47 pm Sale | 2025-08-22 | 13G | Dynavax Technologies Corporation DVAX | Deep Track Capital, LP | 15,726,349 13.410% | -2,065,137 (-11.61%) | Filing History |
| 2025-08-19 4:05 pm Purchase | 2025-08-12 | 13G | X4 Pharmaceuticals, Inc. XFOR | Deep Track Capital, LP | 2,366,995 9.990% | 2,366,995 (New Position) | Filing History |
| 2025-08-14 08:54 am Sale | 2025-06-30 | 13G | Abivax S.A. ABVX | Deep Track Capital, LP | 3,480,144 4.780% | -99,065 (-2.77%) | Filing History |
| 2025-08-14 08:51 am Purchase | 2025-06-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 7,495,000 8.580% | 1,918,442 (+34.40%) | Filing History |
| 2025-08-14 08:50 am Sale | 2025-06-30 | 13G | Zura Bio Limited ZURA | Deep Track Capital, LP | 4,616,514 7.130% | -1,599,813 (-25.74%) | Filing History |
| 2025-08-14 08:50 am Sale | 2025-06-30 | 13G | Regulus Therapeutics Inc. RGLS | Deep Track Capital, LP | 0 0.000% | -6,888,424 (Position Closed) | Filing History |
| 2025-08-14 08:49 am Sale | 2025-06-30 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital, LP | 3,947,807 6.430% | -1,802,193 (-31.34%) | Filing History |
| 2025-08-14 08:48 am Sale | 2025-06-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Deep Track Capital, LP | 2,188,592 6.550% | -830,343 (-27.50%) | Filing History |
| 2025-08-14 08:48 am Purchase | 2025-06-30 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital, LP | 3,948,910 9.020% | 925,426 (+30.61%) | Filing History |